Carolyn Schanen
Research Subjects
Carolyn Schanen has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Jane Lane
Department of Pediatrics; Civitan International Research Center, The University of Alabama at Birmingham; Birmingham Alabama
2 shared publicationsNaghmeh Dorrani
Department of Human Genetics, University of California, Los Angeles, California
2 shared publicationsSara Hammer
Department of Human Genetics, UCLA School of Medicine, Los Angeles, California, USA
2 shared publications- Alan K. Percy
Department of Pediatrics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Division of Pediatric Neurology, Children's of Alabama, Birmingham, Alabama
1 shared publication Alan Percy
Department of Pediatrics, University of Alabama, Birmingham, Alabama
1 shared publicationAlice Feng
Department of Human Genetics, University of California, Los Angeles, California
1 shared publication
Latest Publications
- Open Access
- 14 April 2014
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 164 (5) , 1346
Erratum to “Detection of rarely identified multiple mutations inMECP2gene do not contribute to enhanced severity in Rett syndrome”, Am J Med Genet Part A 161A:1638-1646
- 14 April 2014
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 164 (5) , 1346
Open AccessErratum to “Detection of rarely identified multiple mutations inMECP2gene do not contribute to enhanced severity in Rett syndrome”, Am J Med Genet Part A 161A:1638-1646
- 13 May 2004
- Published by Springer Nature in Human Genetics
- Vol. 115 (2) , 104-111
Supernumerary tricentric derivative chromosome 15 in two boys with intractable epilepsy: another mechanism for partial hexasomy
Rearrangements of chromosome 15q, including isodicentric 15 chromosomes and interstitial duplications and triplications, have been previously reported in association with autism spectrum disorders. We have identified two boys with exceptionally large der(15) chromosomes that are tricentric and contain four copies of the proximal long arm, including the Prader Willi/Angelman critical region, and leading to hexasomy of the involved segment. Biallelic inheritance of maternal alleles and methylation analysis indicate that the markers are maternally derived. Clinical assessment of the boys indicated severe cognitive impairment associated with marked delays in gross and fine motor skills. Social and language deficits were present in both, although the severity of the mental retardation precluded diagnosis of autism (both were considered to have pervasive developmental disorder-not otherwise specified). Neurologic manifestations included infantile spasms evolving into intractable early-onset myoclonic seizures, psychomotor regression, and profound diffuse hypotonia. These patients represent the most severe end of the spectrum of phenotypes associated with segmental aneuploidy for chromosome 15q11-q13.
- 13 May 2004
- Published by Springer Nature in Human Genetics
- Vol. 115 (2) , 104-111
Supernumerary tricentric derivative chromosome 15 in two boys with intractable epilepsy: another mechanism for partial hexasomy
Rearrangements of chromosome 15q, including isodicentric 15 chromosomes and interstitial duplications and triplications, have been previously reported in association with autism spectrum disorders. We have identified two boys with exceptionally large der(15) chromosomes that are tricentric and contain four copies of the proximal long arm, including the Prader Willi/Angelman critical region, and leading to hexasomy of the involved segment. Biallelic inheritance of maternal alleles and methylation analysis indicate that the markers are maternally derived. Clinical assessment of the boys indicated severe cognitive impairment associated with marked delays in gross and fine motor skills. Social and language deficits were present in both, although the severity of the mental retardation precluded diagnosis of autism (both were considered to have pervasive developmental disorder-not otherwise specified). Neurologic manifestations included infantile spasms evolving into intractable early-onset myoclonic seizures, psychomotor regression, and profound diffuse hypotonia. These patients represent the most severe end of the spectrum of phenotypes associated with segmental aneuploidy for chromosome 15q11-q13.
- 24 October 2003
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 126A (2) , 129-140
Phenotypic manifestations of MECP2 mutations in classical and atypical rett syndrome
Since the identification of mutations in MECP2 in girls and women with apparent Rett syndrome, numerous efforts have been made to develop phenotype‐genotype correlations. These studies have produced conflicting results in part related to use of different clinical severity scales, different diagnostic criteria, and different stratification by age and mutation group as well as the possible effects of unbalanced X‐chromosome inactivation. The present study applied a revised ordinal scoring system that allowed for correction for patient ages. We analyzed 85 patients with mutation in MECP2. Sixty‐five (76%) had one of eight common mutations. Patients with missense mutations had lower total severity scores and better language performance than those with nonsense mutations. No difference was noted between severity scores for mutations in the methyl‐binding domain (MBD) and the transcriptional repression domain (TRD). However, patients with missense mutations in TRD had the best overall scores and better preservation of head growth and language skills. Analysis of specific mutation groups demonstrated a striking difference for patients with the R306C mutation including better overall score, later regression, and better language with less motoric impairment. Indeed, these patients as a group accounted for the differences in overall scores between the missense and nonsense groups. Thus, the impact of specific mutations coupled with possible variation in X‐chromosome inactivation must be considered carefully in the derivation of phenotype‐genotype correlations. These results emphasize the limitations of such analyses in larger mutation groups, either by type or position.
- 24 October 2003
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 126A (2) , 129-140
Phenotypic manifestations of MECP2 mutations in classical and atypical rett syndrome
Since the identification of mutations in MECP2 in girls and women with apparent Rett syndrome, numerous efforts have been made to develop phenotype‐genotype correlations. These studies have produced conflicting results in part related to use of different clinical severity scales, different diagnostic criteria, and different stratification by age and mutation group as well as the possible effects of unbalanced X‐chromosome inactivation. The present study applied a revised ordinal scoring system that allowed for correction for patient ages. We analyzed 85 patients with mutation in MECP2. Sixty‐five (76%) had one of eight common mutations. Patients with missense mutations had lower total severity scores and better language performance than those with nonsense mutations. No difference was noted between severity scores for mutations in the methyl‐binding domain (MBD) and the transcriptional repression domain (TRD). However, patients with missense mutations in TRD had the best overall scores and better preservation of head growth and language skills. Analysis of specific mutation groups demonstrated a striking difference for patients with the R306C mutation including better overall score, later regression, and better language with less motoric impairment. Indeed, these patients as a group accounted for the differences in overall scores between the missense and nonsense groups. Thus, the impact of specific mutations coupled with possible variation in X‐chromosome inactivation must be considered carefully in the derivation of phenotype‐genotype correlations. These results emphasize the limitations of such analyses in larger mutation groups, either by type or position.
- 3 June 2003
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 122A (3) , 223-226
Rett syndrome in a 47,XXX patient with a de novo MECP2 mutation
Rett syndrome is caused by mutation in MECP2, a gene located on Xq28 and subject to X‐inactivation. MECP2 encodes methyl CpG‐binding protein 2, a widely expressed transcriptional repressor of methylated DNA. Mutations in MECP2 are primarily de novo events in the male germ line and thus lead to an excess of affected females. Here we report the identification of a unique 47,XXX girl with relatively mild atypical Rett syndrome leading initially to a diagnosis of infantile autism with regression. Mutation analysis of the MECP2 gene identified a de novo MECP2 mutation, L100V. Examination of a panel of X‐linked microsatellite markers indicated that her supernumerary X chromosome is maternally derived. X‐inactivation patterns were determined by analysis of methylation of the androgen receptor locus, and indicated preferential inactivation of her paternal allele. The parental origin of her MECP2 mutation could not be determined because she was uninformative for intronic polymorphisms flanking her mutation. This is the first reported case of sex chromosome trisomy and MECP2 mutation in a female, and it illustrates the importance of allele dosage on the severity of Rett syndrome phenotype.
- 3 June 2003
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 122A (3) , 223-226
Rett syndrome in a 47,XXX patient with a de novo MECP2 mutation
Rett syndrome is caused by mutation in MECP2, a gene located on Xq28 and subject to X‐inactivation. MECP2 encodes methyl CpG‐binding protein 2, a widely expressed transcriptional repressor of methylated DNA. Mutations in MECP2 are primarily de novo events in the male germ line and thus lead to an excess of affected females. Here we report the identification of a unique 47,XXX girl with relatively mild atypical Rett syndrome leading initially to a diagnosis of infantile autism with regression. Mutation analysis of the MECP2 gene identified a de novo MECP2 mutation, L100V. Examination of a panel of X‐linked microsatellite markers indicated that her supernumerary X chromosome is maternally derived. X‐inactivation patterns were determined by analysis of methylation of the androgen receptor locus, and indicated preferential inactivation of her paternal allele. The parental origin of her MECP2 mutation could not be determined because she was uninformative for intronic polymorphisms flanking her mutation. This is the first reported case of sex chromosome trisomy and MECP2 mutation in a female, and it illustrates the importance of allele dosage on the severity of Rett syndrome phenotype.
- 1 January 2002
- Published by Wiley in Mental Retardation and Developmental Disabilities Research Reviews
- Vol. 8 (2) , 94-98
The phenotypic consequences of MECP2 mutations extend beyond rett syndrome
Although MECP2 was initially identified as the causative gene in classic Rett syndrome (RTT), the gene has now been implicated in several phenotypes that extend well beyond the clinically defined disorder. MECP2 mutations have been found in people with various disorders, including neonatal onset encephalopathy, X‐linked recessive mental retardation (MRX), classic and atypical RTT, autism, and Angelman syndrome, as well as mildly affected females and normal carrier females. To make matters more complex, in approximately 20% of classic sporadic RTT cases and more than 50% of affected sister pairs, no mutation in MECP2 has been found. X‐chromosome inactivation patterns can clearly affect the phenotypic expression in females, while the effect of the type and position of the mutation is more apparent in the broader phenotype than in RTT. Both males and females are at risk, although an excess of paternally derived mutations are found in most cases of classic RTT. Thus, because of the range of disparate phenotypes, the gene may account for a relatively large portion of mental retardation in the population. MRDD Research Reviews 2002;8:94–98.
- 1 January 2002
- Published by Wiley in Mental Retardation and Developmental Disabilities Research Reviews
- Vol. 8 (2) , 94-98
The phenotypic consequences of MECP2 mutations extend beyond rett syndrome
Although MECP2 was initially identified as the causative gene in classic Rett syndrome (RTT), the gene has now been implicated in several phenotypes that extend well beyond the clinically defined disorder. MECP2 mutations have been found in people with various disorders, including neonatal onset encephalopathy, X‐linked recessive mental retardation (MRX), classic and atypical RTT, autism, and Angelman syndrome, as well as mildly affected females and normal carrier females. To make matters more complex, in approximately 20% of classic sporadic RTT cases and more than 50% of affected sister pairs, no mutation in MECP2 has been found. X‐chromosome inactivation patterns can clearly affect the phenotypic expression in females, while the effect of the type and position of the mutation is more apparent in the broader phenotype than in RTT. Both males and females are at risk, although an excess of paternally derived mutations are found in most cases of classic RTT. Thus, because of the range of disparate phenotypes, the gene may account for a relatively large portion of mental retardation in the population. MRDD Research Reviews 2002;8:94–98.